Clinical Trials Directory

Trials / Completed

CompletedNCT02275962

Drug-Drug Interaction Study in Healthy Adult Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Kowa Research Institute, Inc. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the effects of rifampin on the pharmacokinetics of K-877 in healthy adult volunteers.

Conditions

Interventions

TypeNameDescription
DRUGK-877
DRUGRifampin

Timeline

Start date
2014-09-01
Primary completion
2014-10-01
Completion
2015-05-01
First posted
2014-10-27
Last updated
2016-02-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02275962. Inclusion in this directory is not an endorsement.